Each year, World Bipolar Day is an opportunity to raise awareness and deepen understanding of bipolar disorder, a condition ...

AZ has yet to file for approval of Imfinzi in the frontline setting for earlier-stage HCC, despite its well-established role ...

The Roivant group company said that treatment with batoclimab had shown some improvement in the eye bulging (proptosis) ...

A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...

Finally, New York's Gilgamesh Pharma – a spinout company formed when AbbVie bought Gilgamesh Pharmaceuticals and its ...

Trump started the Section 232 probe into pharma in the spring of 2025, using it as a lever for trade negotiations and MFN ...

For Lebrat, it goes back to simplicity of use: the synthetic persona leverages the data a team already has. Synthetic ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

For Korsana, merging with Cyclerion gives it a fast track to a Nasdaq listing without the complexities of going down the IPO ...

The move comes as Novo Nordisk is experiencing a slowdown in sales growth for Wegovy, with its US revenues from the drug ...

In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...

Three behavioural phenomena are particularly consequential in screening and prevention research: ...